Rosalie A Carr1, Michele T Yip-Schneider2, Scott Dolejs3, Bradley A Hancock3, Huangbing Wu1, Milan Radovich4, C Max Schmidt5. 1. Department of Surgery, Indiana University School of Medicine; Indiana University Health Pancreatic Cyst and Cancer Early Detection Center, Indianapolis, IN. 2. Department of Surgery, Indiana University School of Medicine; Department of Walther Oncology Center; Indiana University Cancer Center; Indiana University Health Pancreatic Cyst and Cancer Early Detection Center, Indianapolis, IN. 3. Department of Surgery, Indiana University School of Medicine. 4. Department of Surgery, Indiana University School of Medicine; Department of Walther Oncology Center; Indiana University Cancer Center. 5. Department of Surgery, Indiana University School of Medicine; Department of Biochemistry/Molecular Biology, Indiana University School of Medicine; Department of Walther Oncology Center; Indiana University Cancer Center; Indiana University Health Pancreatic Cyst and Cancer Early Detection Center, Indianapolis, IN. Electronic address: maxschmi@iupui.edu.
Abstract
BACKGROUND: Accurate differentiation of pancreatic cystic lesions is important for pancreatic cancer early detection and prevention as well as avoidance of unnecessary surgical intervention. Serous cystic neoplasms (SCN) have no malignant potential, but may mimic premalignant mucinous cystic lesions: mucinous cystic neoplasm (MCN) and intraductal papillary mucinous neoplasm (IPMN). We recently identified vascular endothelial growth factor (VEGF)-A as a novel pancreatic fluid biomarker for SCN. We hypothesize that combining cyst fluid carcinoembryonic antigen (CEA) with VEGF-A will improve the diagnostic accuracy of VEGF-A. METHODS: Pancreatic cyst/duct fluid was collected from consenting patients undergoing surgical cyst resection with corresponding pathologic diagnoses. Pancreatic fluid VEGF-A and CEA levels were detected by ELISA. RESULTS: One hundred forty-nine patients with pancreatic cystic lesions met inclusion criteria. Pathologic diagnoses included pseudocyst (n=14), SCN (n=26), MCN (n=40), low/moderate grade IPMN (n=34), high grade IPMN (n=20), invasive IPMN (n=10) and solid pseudopapillary neoplasm (n=5). VEGF-A was significantly elevated in SCN cyst fluid compared to all other diagnoses (p<0.001). With a threshold of >5,000 pg/ml, VEGF-A alone has 100% sensitivity and 83.7% specificity to distinguish SCN from other cystic lesions. With a threshold of ≤10ng/ml, CEA alone identifies SCN with 95.5% sensitivity and 81.5% specificity. Sensitivity and specificity of the VEGF-A/CEA combination are 95.5% and 100% respectively. The c-statistic increased from 0.98 to 0.99 when CEA was added to VEGF-A alone in the ROC analysis. CONCLUSIONS: Although VEGF-A alone is a highly accurate test for SCN, the combination of VEGF-A with CEA approaches the gold-standard of pathologic diagnosis, thus importantly avoiding false positives. Patients with a positive test indicating benign SCN can be spared a high risk surgical pancreatic resection.
BACKGROUND: Accurate differentiation of pancreatic cystic lesions is important for pancreatic cancer early detection and prevention as well as avoidance of unnecessary surgical intervention. Serous cystic neoplasms (SCN) have no malignant potential, but may mimic premalignant mucinous cystic lesions: mucinous cystic neoplasm (MCN) and intraductal papillary mucinous neoplasm (IPMN). We recently identified vascular endothelial growth factor (VEGF)-A as a novel pancreatic fluid biomarker for SCN. We hypothesize that combining cyst fluid carcinoembryonic antigen (CEA) with VEGF-A will improve the diagnostic accuracy of VEGF-A. METHODS:Pancreatic cyst/duct fluid was collected from consenting patients undergoing surgical cyst resection with corresponding pathologic diagnoses. Pancreatic fluid VEGF-A and CEA levels were detected by ELISA. RESULTS: One hundred forty-nine patients with pancreatic cystic lesions met inclusion criteria. Pathologic diagnoses included pseudocyst (n=14), SCN (n=26), MCN (n=40), low/moderate grade IPMN (n=34), high grade IPMN (n=20), invasive IPMN (n=10) and solid pseudopapillary neoplasm (n=5). VEGF-A was significantly elevated in SCN cyst fluid compared to all other diagnoses (p<0.001). With a threshold of >5,000 pg/ml, VEGF-A alone has 100% sensitivity and 83.7% specificity to distinguish SCN from other cystic lesions. With a threshold of ≤10ng/ml, CEA alone identifies SCN with 95.5% sensitivity and 81.5% specificity. Sensitivity and specificity of the VEGF-A/CEA combination are 95.5% and 100% respectively. The c-statistic increased from 0.98 to 0.99 when CEA was added to VEGF-A alone in the ROC analysis. CONCLUSIONS: Although VEGF-A alone is a highly accurate test for SCN, the combination of VEGF-A with CEA approaches the gold-standard of pathologic diagnosis, thus importantly avoiding false positives. Patients with a positive test indicating benign SCN can be spared a high risk surgical pancreatic resection.
Authors: Purvi Parikh; Mira Shiloach; Mark E Cohen; Karl Y Bilimoria; Clifford Y Ko; Bruce L Hall; Henry A Pitt Journal: HPB (Oxford) Date: 2010-09 Impact factor: 3.647
Authors: B Jais; V Rebours; G Malleo; R Salvia; M Fontana; L Maggino; C Bassi; R Manfredi; R Moran; A M Lennon; A Zaheer; C Wolfgang; R Hruban; G Marchegiani; C Fernández Del Castillo; W Brugge; Y Ha; M H Kim; D Oh; I Hirai; W Kimura; J Y Jang; S W Kim; W Jung; H Kang; S Y Song; C M Kang; W J Lee; S Crippa; M Falconi; I Gomatos; J Neoptolemos; A C Milanetto; C Sperti; C Ricci; R Casadei; M Bissolati; G Balzano; I Frigerio; R Girelli; M Delhaye; B Bernier; H Wang; K T Jang; D H Song; M T Huggett; K W Oppong; L Pererva; K V Kopchak; M Del Chiaro; R Segersvard; L S Lee; D Conwell; A Osvaldt; V Campos; G Aguero Garcete; B Napoleon; I Matsumoto; M Shinzeki; F Bolado; J M Urman Fernandez; M G Keane; S P Pereira; I Araujo Acuna; E C Vaquero; M R Angiolini; A Zerbi; J Tang; R W Leong; A Faccinetto; G Morana; M C Petrone; P G Arcidiacono; J H Moon; H J Choi; R S Gill; D Pavey; M Ouaïssi; B Sastre; M Spandre; C G De Angelis; M A Rios-Vives; M Concepcion-Martin; T Ikeura; K Okazaki; L Frulloni; O Messina; P Lévy Journal: Gut Date: 2015-06-04 Impact factor: 23.059
Authors: Michele T Yip-Schneider; Huangbing Wu; Ryan P Dumas; Brad A Hancock; Narasimhan Agaram; Milan Radovich; C Max Schmidt Journal: J Am Coll Surg Date: 2013-12-24 Impact factor: 6.113
Authors: Asif Khalid; Maliha Zahid; Sydney D Finkelstein; Julia K LeBlanc; Neeraj Kaushik; Nuzhat Ahmad; William R Brugge; Steven A Edmundowicz; Robert H Hawes; Kevin M McGrath Journal: Gastrointest Endosc Date: 2009-01-18 Impact factor: 9.427
Authors: Mohammad Al-Haddad; John DeWitt; Stuart Sherman; C Max Schmidt; Julia K LeBlanc; Lee McHenry; Gregory Coté; Abdul Hamid El Chafic; Leticia Luz; Jennifer Schaffter Stuart; Cynthia S Johnson; Christen Klochan; Thomas F Imperiale Journal: Gastrointest Endosc Date: 2013-07-09 Impact factor: 9.427
Authors: Abdurrahman Kadayifci; Mustafa Atar; Jessica L Wang; David G Forcione; Brenna W Casey; Martha B Pitman; William R Brugge Journal: Dig Endosc Date: 2016-10-04 Impact factor: 7.559
Authors: Zachary E Stiles; Sheema Khan; Kurt T Patton; Meena Jaggi; Stephen W Behrman; Subhash C Chauhan Journal: HPB (Oxford) Date: 2018-08-14 Impact factor: 3.647
Authors: Simeon Springer; David L Masica; Marco Dal Molin; Christopher Douville; Christopher J Thoburn; Bahman Afsari; Lu Li; Joshua D Cohen; Elizabeth Thompson; Peter J Allen; David S Klimstra; Mark A Schattner; C Max Schmidt; Michele Yip-Schneider; Rachel E Simpson; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; William Brugge; Randall E Brand; Aatur D Singhi; Aldo Scarpa; Rita Lawlor; Roberto Salvia; Giuseppe Zamboni; Seung-Mo Hong; Dae Wook Hwang; Jin-Young Jang; Wooil Kwon; Niall Swan; Justin Geoghegan; Massimo Falconi; Stefano Crippa; Claudio Doglioni; Jorge Paulino; Richard D Schulick; Barish H Edil; Walter Park; Shinichi Yachida; Susumu Hijioka; Jeanin van Hooft; Jin He; Matthew J Weiss; Richard Burkhart; Martin Makary; Marcia I Canto; Michael G Goggins; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Sillman; Maria Popoli; Alison P Klein; Cristian Tomasetti; Rachel Karchin; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Christopher L Wolfgang; Ralph H Hruban; Anne Marie Lennon Journal: Sci Transl Med Date: 2019-07-17 Impact factor: 17.956
Authors: Michele T Yip-Schneider; Huangbing Wu; Hannah R Allison; Jeffrey J Easler; Stuart Sherman; Mohammad A Al-Haddad; John M Dewitt; C Max Schmidt Journal: J Am Coll Surg Date: 2021-06-21 Impact factor: 6.532